Cargando…
Immunization of Rabbits with a Quadrivalent Shigella Bioconjugate Vaccine Induces Functional Antibodies Reactive with Shigella Isolates from Kenya
Diarrheal diseases are a leading cause of global morbidity and mortality, disproportionately affecting children in resource-limited settings. Although improvements in hygiene and access to clean water are helpful, vaccines are considered essential due to the low infectious dose of Shigella species a...
Autores principales: | Odundo, Elizabeth A., Weerts, Hailey P., Musila, Lillian, Ogonda, Lilian, Dreyer, Anita M., Schneider, Joerg, Carranza, Paula, Kaminski, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241535/ https://www.ncbi.nlm.nih.gov/pubmed/35611657 http://dx.doi.org/10.1128/msphere.01020-21 |
Ejemplares similares
-
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
por: Talaat, Kawsar R., et al.
Publicado: (2021) -
Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate
por: Ravenscroft, Neil, et al.
Publicado: (2019) -
Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine
por: Clarkson, Kristen A., et al.
Publicado: (2021) -
The Ongoing Journey of a Shigella Bioconjugate Vaccine
por: Martin, Patricia, et al.
Publicado: (2022) -
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
por: Riddle, Mark S., et al.
Publicado: (2016)